App-Quantinova.ai

Two Years Results Following Bioresorbable Vascular Scaffold Implantation in ST-Segment Elevation Myocardial Infarction Patients

Alfonso Ielasi - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Rotational Atherectomy and Stenting of Severely Calcified Coronary Arteries with Absorb Bioresorbable Vascular Scaffolds: Analysis of Outcomes

Babu Ezhumalai - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Long-Term Clinical Impact of Complete Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease

Min Chul Kim - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Safety and Efficacy of Using a Single Transradial MAC Guiding Catheter for Coronary Angiography and Intervention in Patients with STE-Myocardial Infarction (RAPID)

Jincheng Guo - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Immediate and Mid-Term Results of the Use of Antiembolic Mesh-Covered Stents Mguar- in Patients with Acute ST-Elevation Coronary Syndrome

Dzhamil Arif Ogly Asadov - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Comparison of Direct Stenting Versus Pre-Dilation in ST-Elevation Myocardial Infarction

Nino V. Tsereteli - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Efficacy of Long 2nd Generation Drug-Eluting Stent Implantation from Healthy to Healthy Segment Under Intravascular Ultrasound Guidance in Acute Myocardial Infarction

Shota Ikeda - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Everolimus- Versus Zotarolimus-Eluting Stents for Treatment of Unprotected Left Main Coronary Artery Lesions (From an IRIS-MAIN Registry Substudy)

Yu Na Kim - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Outcome of Everolimus Eluting Bioabsorbable Vascular Scaffold(BVS) Compared to Non BVS Drug Eluting Stent in the Management of ST-Segment Elevation Myocardial Infarction(STEMI) - A Comparative Study

Soumya Patra - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Coronary Computed Tomography Angiography Guided Percutaneous Coronary Intervention Using Bioresorbable Scaffolds in Calcified Coronary Stenoses

Michael Chun-Leng Lim - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Optical Coherence Tomography Guided Assessment of Outcomes After Implantation of Bioresorbable Stents at Mid Term Follow-up in Indian Patients

Manojkumar Rohit - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Medium Term Target Lesion Failure in Patient Treated with Bioresorbable Vascular Scaffold

Michael Mao-Chen Liang - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Absorb Bioresorbable Vascular Scaffolds in the Treatment of Chronic Total Occlusion of Coronary Arteries: Utility and Outcomes

Babu Ezhumalai - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Outcomes in Patients with Triple Vessel Disease Undergoing Coronary Artery Bypass Graft

Gopal Murugesan - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Outcomes of Full Metal Jacket Procedure After Percutaneous Coronary Intervention for Chronic Total Occlusion

Cheol Hyun Lee - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Hospital and Long-Term Results of Endovascular Treatment of Patients with Acute Myocardial Infarction Complicated with Primary Ventricular Fibrillation

Se Yong Jung - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Transradial Cardiac Catheterization and Endothelial Dysfunction

Ashwin Lysander - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroglycerin

Bleeding and Major Adverse Cardiac Events in Non-Cardiac Surgery, Within 2 Years Post Percutaneous Coronary Intervention

Tamer Naguib Badie - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Tirofiban hydrocloride

Incidence and Clinical Outcomes of Stent Fractures Based on 3411 Patients and 5836 Drug-Eluting Stents: A One-Year Analysis After Index Stenting Procedures

Shaoliang Chen - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

TAXUS

Impact of Everolimus-Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention

Hideki Yano - Angioplasty Summit-TCTAP , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Filters

7277 Abstracts